AONN+ Statement of Professional Responsibility to Ensure Racial and Health Equity

News & Updates published on June 4, 2020 in News & Updates

The Academy of Oncology Nurse & Patient Navigators (AONN+) is dedicated to improving patient care and quality of life. We are committed to supporting the professional workforce that has historically served cancer patients in greatest need. This includes patients of color who have long dealt with systemic and institutional injustices and racial inequities. These impacts have been well documented in our health and cancer care systems and were the catalyst to create the profession of navigation.

We stand at a moment of national tragedy, built on a history of racial injustice. This is compounded by the disproportionate impact of COVID-19 on communities of color. Navigators work to make our healthcare system a more just and equitable place as they help patients identify personal strengths to empower their preference and priorities. They bear witness to the extraordinary challenges facing all cancer patients. A core competency of patient navigation is to demonstrate sensitivity and responsiveness to a diverse patient population, including, but not limited to, diversity in race, ethnicity, gender, age, culture, religion, abilities, and sexual orientation. With this basic value, all navigators work to expose health inequities and find solutions to ensure that all people have the opportunity to live healthy, fulfilling lives as they respond to patient needs and barriers. The need for this work has never been more profound. AONN+ implores all navigators to recommit in this moment to their professional obligations to advance racial and health equity.

Related Items
AONN+'s ER+ Premenopausal Breast Cancer Journey Pathway Wins PM360 Pharma Choice Award
Press Releases published on February 28, 2024 in News & Updates
Cranbury, NJ (February 28, 2024)—The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to share that PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostic industries, has named AONN+’s estrogen-receptor-positive (ER+) Premenopausal Breast Cancer Journey Pathway, supported by TerSera Therapeutics, as the Pharma Choice Award – Variety Silver Winner.
The Academy of Oncology Nurse & Patient Navigators (AONN+) Selects Sites to Participate in National Acuity Quality Initiative
Press Releases published on October 4, 2023 in News & Updates
CRANBURY, NJ (Oct. 4, 2023) – The Academy of Oncology Nurse & Patient Navigators’ (AONN+) National Navigation Acuity Taskforce is developing a standardized, validated, evidence-based Navigation Acuity Tool for oncology navigation programs. When finalized, the acuity tool is expected to help oncology navigators characterize the intensity of the patient navigation workload, aid in the allocation of resources, and measure the effectiveness of navigation on patient outcomes.
The Academy of Oncology Nurse & Patient Navigators (AONN+) Announces New Leadership Council Members
Press Releases published on August 16, 2023 in News & Updates
CRANBURY, NJ—Each year, the AONN+ Leadership Council strives to bring novel ideas and perspectives to the table through the addition of new members.